Delivery Order SPE2DB20D3303-SPE2DB25FA2UE
- Not listed
- The Defense Logistics Agency awarded a $2,703.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Sacubitril-Valsartan 24-26 mg tablets (60-count). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 5, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of AmerisourceBergen's ongoing pharmaceutical supply operations...
- The Defense Logistics Agency awarded a delivery order valued at $1,054.55 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCZ 160-25 mg tablets (90-count) on August 19, 2025, with completion scheduled for August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's substantial pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Valsartan-HCZ 320-25 mg tablets (90-count) with a ceiling value of $3,727.23. This is a firm fixed price, non-set-aside delivery order that represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Valsartan 320 mg tablets (90-count) with a ceiling value of $1,165.45. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count units) with a ceiling value of $2,651.15. This delivery order, issued under firm fixed-price terms with no set-aside designation, represents a competitively awarded procurement from AmerisourceBergen's existing indefinite delivery contract vehicle with the DLA. The product will be performed at the company's Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Valsartan-HCTZ 160-25 mg tablets in quantities of 90 units, with a ceiling value of $3,305.82. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 8, 2025. The award was made to AmerisourceBergen Drug Corp at its Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Valsartan-HCTZ 160-12.5 mg tablets in a quantity of 90 units, with a contract ceiling value of $4,211.74. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for ultimate completion by August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,733.29 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-25 mg tablets (90-count bottles) under a firm fixed-price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and primary...
- The Defense Logistics Agency awarded a $2,069.16 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of AMLOD-VALSA-HCTZ 5-160-25 MG in 30-count packaging. The contract, which is non-set-aside and competitively awarded on a firm fixed price basis, is scheduled for completion by August 5, 2025, with performance to occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $36,196.14 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procedures and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2UEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Sacubitril-Valsartan 24-26 mg in 60-count quantities, with a contract ceiling value of $10,688.40. This firm fixed price delivery order, which carries an ultimate completion date of August 21, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order as part of its broader role as a critical pharmaceutical distributor for military and veteran healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The underlying contract structure reflects DLA's strategic pharmaceutical procurement approach and AmerisourceBergen's established capability to meet federal medical supply needs through competitive procurement channels.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 8/20/25 |